CVS has been ordered to cooperate with an investigation looking into false claim submissions and their pricing of insulin and epinephrine drugs. The article also describes a proposed class action lawsuit pertaining to the increased prices of insulin against Sanofi, Eli Lilly & Co., and Novo Nordisk. Click here to learn more.
- The Next Generation of PBMs: New Technology, Simpler Business Model and More Transparency (Managed Healthcare Executive)
- Upcoming Events
- CVS’ Pharmacy Benefit Manager Unit Sued for False Claims (Modern Healthcare)
- CVS, Walgreens and PBMs Worked Together to Gouge Consumers, Lawsuits Claim (FiercePharma)
- CVS ordered to cooperate in Medicare claims, pricing investigations (CNBC)